
NEONC TECHNOLOGIES HOLDINGS, INC. — Investor Relations & Filings
NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company that has developed a proprietary, patented platform technology for transporting therapeutics directly to the brain. Its core innovation is an intranasal drug delivery system designed to overcome the limitations of the Blood-Brain Barrier (BBB), enabling more effective treatment for Central Nervous System (CNS) diseases. The company's primary focus is on developing novel therapies for brain cancers, such as glioblastoma, with pipeline candidates including NEO100 and NEO212. The platform is also designed to facilitate the transport of established and new third-party therapeutics, aiming to improve efficacy for a wide range of brain-related conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| 10-Q | 2026-05-15 | English | |
| 8-K - NEONC TECHNOLOGIES HOLDINGS, INC. (0001979414) (Filer) | 2026-04-16 | English | |
| 424B5 - NEONC TECHNOLOGIES HOLDINGS, INC. (0001979414) (Filer) | 2026-04-16 | English | |
| S-3 - NEONC TECHNOLOGIES HOLDINGS, INC. (0001979414) (Filer) | 2026-04-10 | English | |
| 8-K - NEONC TECHNOLOGIES HOLDINGS, INC. (0001979414) (Filer) | 2026-04-10 | English |
Browse filings by year
4 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cenra Inc.
Diversified healthcare enterprise providing R&D, manufactur…
|
3716 | TW | Manufacturing |
|
Centessa Pharmaceuticals plc
Clinical-stage pharmaceutical company developing medicines …
|
CNTA | GB | Manufacturing |
|
Century Therapeutics, Inc.
Develops iPSC-derived allogeneic cell therapies for cancer …
|
IPSC | US | Manufacturing |
|
Cereno Scientific AB
Clinical-stage biotech developing drugs for rare cardiovasc…
|
CRNO | SE | Manufacturing |
|
CERO THERAPEUTICS HOLDINGS, INC.
Immunotherapy company developing engineered T cell therapeu…
|
CERO | US | Manufacturing |
|
CERUS CORP
Develops pathogen inactivation technology to reduce transfu…
|
CERS | US | Manufacturing |
|
Cessatech A/S
A biotech company developing medicines for children's acute…
|
CESSA | DK | Manufacturing |
|
CF PharmTech
Develops and manufactures inhalation drugs and delivery sys…
|
2652 | CN | Manufacturing |
|
CF PharmTech, Inc.
Specialty pharmaceutical company developing complex inhalat…
|
2652 | HK | Manufacturing |
|
CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomic…
|
083790 | KR | Manufacturing |
NEONC TECHNOLOGIES HOLDINGS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33805/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33805 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33805 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33805 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33805}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NEONC TECHNOLOGIES HOLDINGS, INC. (id: 33805)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.